Safety and effectiveness of phenobarbital vs. benzodiazepines for severe alcohol withdrawal in alcohol-associated liver disease in the ICU

Background & Aims: Severe alcohol withdrawal syndrome (SAWS) in patients with alcohol-associated liver disease (ALD) presents management challenges due to altered drug metabolism and increased toxicity. While benzodiazepines remain standard therapy, concerns about drug shortages, over-sedation,...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Rajalakshmi Govalan, Shengchen Hao, Michael T. Kenes, Jakob I. McSparron, Elliot B. Tapper
Format:	Artigo
Język:	Inglês
Wydane:	Elsevier 2026-04-01
Seria:	JHEP Reports
Hasła przedmiotowe:	Severe alcohol withdrawal syndrome phenobarbital benzodiazepines alcohol-associated liver disease critical care mechanical ventilation
Dostęp online:	http://www.sciencedirect.com/science/article/pii/S2589555926000406
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!